SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

FAINARDI, Enrico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.959
EU - Europa 2.905
AS - Asia 2.894
SA - Sud America 209
AF - Africa 32
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 9
Totale 16.021
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.927
SG - Singapore 1.276
CN - Cina 1.063
UA - Ucraina 613
IT - Italia 582
DE - Germania 480
TR - Turchia 361
GB - Regno Unito 334
PL - Polonia 250
FI - Finlandia 211
BR - Brasile 196
SE - Svezia 161
ID - Indonesia 61
BE - Belgio 55
FR - Francia 53
HK - Hong Kong 52
AT - Austria 38
CZ - Repubblica Ceca 31
CA - Canada 26
RU - Federazione Russa 23
NL - Olanda 19
IR - Iran 17
VN - Vietnam 17
ZA - Sudafrica 14
LT - Lituania 9
AU - Australia 8
A2 - ???statistics.table.value.countryCode.A2??? 7
IN - India 7
MA - Marocco 7
EU - Europa 6
RO - Romania 6
IE - Irlanda 5
KR - Corea 5
PK - Pakistan 5
PT - Portogallo 5
AR - Argentina 4
BD - Bangladesh 4
BG - Bulgaria 4
CH - Svizzera 4
IQ - Iraq 4
CO - Colombia 3
EC - Ecuador 3
EG - Egitto 3
ES - Italia 3
NG - Nigeria 3
PH - Filippine 3
SI - Slovenia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
DZ - Algeria 2
HR - Croazia 2
HU - Ungheria 2
JM - Giamaica 2
JP - Giappone 2
KE - Kenya 2
LU - Lussemburgo 2
MD - Moldavia 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
AZ - Azerbaigian 1
CL - Cile 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
JO - Giordania 1
KG - Kirghizistan 1
LK - Sri Lanka 1
MG - Madagascar 1
MK - Macedonia 1
MN - Mongolia 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SV - El Salvador 1
TW - Taiwan 1
UY - Uruguay 1
VE - Venezuela 1
Totale 16.021
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.338
Fairfield 1.093
Chandler 767
Houston 716
Jacksonville 673
Ashburn 613
Santa Clara 578
Ann Arbor 561
Singapore 538
Wilmington 394
Seattle 371
Cambridge 360
Warsaw 240
Izmir 234
Nanjing 219
Ferrara 188
Princeton 180
Beijing 163
Milan 143
Boardman 122
New York 116
Shanghai 110
San Diego 90
Addison 81
Dearborn 80
Los Angeles 77
Helsinki 70
Nanchang 66
Shenyang 63
Bremen 59
Jakarta 57
Brussels 55
Hong Kong 52
Jiaxing 50
Hebei 46
Tianjin 43
Changsha 42
Norwalk 38
Falls Church 32
Vienna 30
Brno 29
San Mateo 28
Ningbo 26
Jinan 24
London 23
Orange 23
Redwood City 23
Auburn Hills 21
Bologna 21
Zhengzhou 21
Falkenstein 19
Mountain View 18
Kunming 17
Toronto 17
Guangzhou 16
São Paulo 16
Dong Ket 15
Munich 15
Tappahannock 15
Hefei 14
Nuremberg 14
Taizhou 14
Des Moines 13
Frankfurt am Main 13
Rome 13
Verona 13
Washington 13
Leawood 12
Ardabil 10
Düsseldorf 10
The Dalles 10
Kraków 9
Rio de Janeiro 9
Indiana 8
Philadelphia 8
Augusta 7
Hangzhou 7
Kilburn 7
Ottawa 7
Curitiba 6
Redmond 6
Belo Horizonte 5
Changchun 5
Lanzhou 5
Portsmouth 5
San Francisco 5
Brasília 4
Burnley 4
Clifton 4
Council Bluffs 4
Dublin 4
Haikou 4
Madison 4
Monmouth Junction 4
Parma 4
Simi Valley 4
Stockholm 4
Turin 4
Calderara Di Reno 3
Catania 3
Totale 11.437
Salva come PNG Salva come JPEG
Nome #
Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment 353
HLA-G Molecules in Autoimmune Diseases and Infections 173
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 167
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 164
Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study 158
Timing of serum active MMP-9 and MMP-2 levels in acute and subacute phases after spontaneous intracerebral hemorrhage 157
Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients 156
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 148
Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis 148
Evaluation of acute perihematomal regional apparent diffusion coefficient abnormalities by diffusion-weighted imaging 148
Emerging topics and new perspectives on HLA-G 142
Clinical and MRI disease activity in multiple sclerosis are associated with reciprocal fluctuations in serum and cerebrospinal fluid levels of soluble HLA class I molecules 142
Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke 141
CT perfusion mapping of hemodynamic disturbances associated to acute spontaneous intracerebral hemorrhage 141
Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies 141
Awake surgery in low-grade gliomas harboring eloquent areas: 3-year mean follow-up 140
Chlamydia pneumoniaespecific intrathecal oligoclonal antibody response is predominantly detected in a subset of multiple sclerosis patients with progressive forms 138
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 137
Incidence of neuroepithelial primary brain tumors among adult population of Emilia-Romagna Region, Italy 136
Cerebrospinal fluid analysis and the determination of oligoclonal bands 136
Technical, Anatomical, and Functional Study after Removal of a Symptomatic Cavernous Angioma Located in Deep Wernicke's Territories with Cortico-Subcortical Awake Mapping. 134
Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes 133
Monocyte count at onset predicts poststroke outcomes during a 90-day follow-up 132
Serum IgG against Simian Virus 40 antigens are hampered by high levels of sHLA-G in patients affected by inflammatory neurological diseases, as multiple sclerosis 131
Correlation between auto/mitophagic processes and magnetic resonance imaging activity in multiple sclerosis patients 131
Leptin/adiponectin ratio predicts post-stroke neurological outcome 130
Survival prediction in high-grade gliomas using CT perfusion imaging 129
KIR2DL2 inhibitory pathway enhances Th17 cytokine secretion by NK cells in response to herpesvirus infection in multiple sclerosis patients 128
Intrathecal Soluble HLA-E Correlates with Disease Activity in Patients with Multiple Sclerosis and may Cooperate with Soluble HLA-G in the Resolution of Neuroinflammation. 128
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 126
Spontaneous and idiopathic chronic spinal epidural hematoma: two case reports and review of the literature 123
The role of stage-specific oligonucleotide primers in providing effective laboratory support for the molecular diagnosis of reactivated Toxoplasma gondii encephalitis in patients with AIDS 123
Study of Soluble HLA-G in Congenital Human Cytomegalovirus Infection 123
Assessment of HIV-intrathecal humoral immune response in AIDS-related neurological disorders 123
Alterazioni liquorali nella sindrome di Guillain-Barrè: Utilità nella diagnosi e nel monitoraggio della malattia. 121
null 121
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 121
Spinal anterior epidural hematoma in an elderly man with unrecognized lupic anticoagulant taking warfarin 117
A new developed culture method efficiently supports the growth of Chamydia pneumoniae in PBMC and CSF samples from patients with Multiple Sclerosis 117
Hyperfusion Syndrome Secondary to Carotid Endovascular Rivascularization: a case report 116
Neurofilament ELISA validation 115
A Further Evidence Of Pathogenic Role Of Chlamydia Pneumoniae In Multiple Sclerosis 113
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 113
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 112
Recent advances in our understanding of HLA-G biology: Lessons from a wide spectrum of human diseases 111
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 111
null 110
Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings 109
null 109
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 108
The incidence of Guillain-Barrè syndrome in Ferrara, Italy: is the disease really increasing? 108
New insights into HLA-G and inflammatory diseases 107
Some basic aspects of HLA-G biology. 107
Intrathecal production of Chlamydia pneumoniae-specific high-affinity antibodies is significantly associated to a subset of multiple sclerosis patients with progressive forms 107
Hyperperfusion syndrome secondary to carotid endovascular rivascularization: a case report 107
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 106
Temporal changes in CT perfusion values before and after cranioplasty in patients without symptoms related to external decompression: A pilot study 106
Affinity distribution of anti-EBV IgG in the cerebrospinal fluid of patients with multiple sclerosis and in controls 105
null 104
Exogenous gangliosides and Guillain-Barre syndrome. An observational study in the Local Health District of Ferrara, Italy 103
Detection of JC virus DNA in cerebrospinal fluid from multiple sclerosis patients 103
null 102
DNA Sequences of Parachlamydia-like organisms in CSF of Patients with Neurological Disorders 102
Clinical and MRI activity are associated to elevated cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-9 in multiple sclerosis patients 102
Timing of serum soluble HLA-G levels in acute and subacute phases after spontaneous intracerebral hemorrhage. 102
CEREBROSPINAL FLUID AND SERUM LEVELS OF ANTI-CHLAMYDIA PNEUMONIAE IGA IN PATIENTS WITH MULTIPLE SCLEROSIS 101
Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients 99
Effect of pH on MMP-9 release by LPS-stimulated neutrophils 98
Quantification of CSF and serum levels and intrathecal synthesis of anti-EBV antibodies in patients with multiple sclerosis and with other neurological disorders. 98
null 97
Antigeni solubili di classe I classici e non classici (sHLA G) nei fluidi cerebrospinali della sclerosi multipla 97
null 97
25 hydroxyvitamin D in cerebrospinal fluid from patients with multiple sclerosis during relapse and remission 97
Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient 97
null 96
Decrease Paraoxonase-1 (PON-1) Activities in Neurodegenerative Diseases 95
SERUM GELATINASES LEVELS IN MULTIPLE SCLEROSIS PATIENTS DURING 21 MONTHS OF NATALIZUMAB TREATMENT 93
Cerebrospinal fluid (CSF) Protein Immunoglobulin and cellular abnormalities in Acquired Immune Deficiency Syndrome (AIDS) 92
Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies 91
Impaired Cerebral Venous Haemodynamics In Multiple Sclerosis Patients 90
INTRATHECAL PRODUCTION OF ACTIVE FORM OF MATRIX METALLOPROTEINASES-9 IN PATIENTS WITH MULTIPLE SCLEROSIS: PRELIMINARY RESULTS” 90
null 90
Inflammation and axonal damage biomarkers in Multiple Sclerosis: new perspective on their role 89
Therapeutic plasma exchange for worsening relapsing remitting multiple sclerosis. A case report 88
Le catene leggere libere liquorale sclerosi multipla 88
null 88
null 87
Altered miRNA expression in T regulatory cells in course of multipla sclerosis 87
The role of [123I]-FP-CIT SPECT in the diagnosis and clinical menagement of Parkinson's disease 87
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 are elevated in in multiple sclerosis patients with disease activity 86
Analysis of MMP-9 in CSF and sera of patients with neurological diseases 86
Cerebrospinal fluid oligoclonal free light chain profiles in AIDS 85
Detection of Parachlamydialike organisms in patients with multiple sclerosis. 84
Inverse association between CSF levels of solubile HLA-G and Fas molecules in MS patients with no evidence of MRI disease activity. 84
null 84
null 84
null 83
Decreased serum PCSK9 levels after ischemic stroke predict worse outcomes 83
Significance of anti-Chlamydophila pneumoniae IgA and IgG determination in patients with acute and post-acute ischaemic stroke 81
Chlamydia pneumonia-specific CFS-restricted oligoclonal IgG bands are associated to a subset of patients with prosessive forms of multiple sclerosis. 80
Totale 11.507
Salva come PNG Salva come JPEG
Categoria #
all - tutte 87.394
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 713
Totale 88.107
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020451 0 0 0 0 0 0 0 0 0 296 102 53
2020/20211.843 153 131 72 195 78 178 64 221 70 270 283 128
2021/20221.609 84 183 96 51 54 73 76 94 52 143 133 570
2022/20231.809 182 154 69 247 279 237 122 168 208 7 92 44
2023/20241.050 95 107 52 28 110 198 35 89 31 29 24 252
2024/20252.891 103 92 310 158 530 353 98 156 767 324 0 0
Totale 16.311